Results 191 to 200 of about 665,576 (285)
ABSTRACT Mosunetuzumab is approved as an intravenous (IV) formulation for relapsed/refractory (R/R) follicular lymphoma (FL) after ≥ 2 prior therapies. A subcutaneous (SC) formulation, aiming to improve patient safety and convenience, has been developed.
Nancy L. Bartlett +20 more
wiley +1 more source
Guest Editorial: Contemporary Issues at the intersection of Intellectual Property Law and Society
Smita Kheria
doaj +1 more source
The EAES intellectual property protection guide. [PDF]
Nakajima K +4 more
europepmc +1 more source
Table of Contents - Issue 1 & 2 [PDF]
Buffalo Intellectual Property Law Journal
core +1 more source
ABSTRACT Background A causal association between occupational asbestos exposure and lung disease, including pneumoconiosis and mesothelioma, is well established. Elevated mortality among former asbestos miners is expected. However, large‐scale South African studies examining all‐cause mortality in this population are lacking.
Yumna Williams‐Mohamed +3 more
wiley +1 more source
Health equity and the global social contract: beyond incrementalism and illusionary solidarity. [PDF]
Mulumba M +4 more
europepmc +1 more source
ABSTRACT In 2019, the Australian government established the Royal Commission into Violence, Abuse, Neglect and Exploitation of People with Disability (‘Disability Royal Commission’, DRC) to investigate widespread mistreatment of people with disability. Nearly 10,000 people with disability, their families and supporters engaged with the DRC.
Kate D'Cruz +7 more
wiley +1 more source
Policy and legal perspectives on the traditional Chinese medicine varietal protection system (TCMVPS): reform or abolition? [PDF]
Wang Y, Sun K, Hua D.
europepmc +1 more source
ABSTRACT Diagnoses of autism spectrum disorder in Australia have increased considerably in recent years. The current study investigated how the National Disability Insurance Scheme (NDIS) impacts quality of life (QoL) among carers of children with autism spectrum disorder.
Jesse Gerhard, Sharon L. Grant
wiley +1 more source
Reigniting the institutional engine for pharmaceutical access: when policy experiments become new global evidence. [PDF]
Chen J, Li W.
europepmc +1 more source

